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Abstract The active site of Escherichia coli glutaredoxin-3
(Grx3) consists of two redox active cysteine residues in the
sequence -C11-P-Y-C14-H-. The 1H NMR resonance of the
cysteine thiol proton of Cys-14 in reduced Grx3 is observed at 7.6
ppm. The large downfield shift and NOEs observed with this thiol
proton resonance suggest the presence of a hydrogen bond with
the Cys-11 thiolate, which is shown to have an abnormally low
pKa value. A hydrogen bond would also agree with activity data
of Grx3 active site mutants. Furthermore, the activity is reduced
in a Grx3 H15V mutant, indicating electrostatic contributions to
the stabilization of the Cys-11 thiolate.
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1. Introduction
Glutaredoxins (Grxs) are members of a family of thiol-di-
sul¢de oxidoreductases, including thioredoxin (Trx), protein
disul¢de isomerase (PDI) and DsbA. These enzymes have a
redox active disul¢de and a similar architecture, known as the
thioredoxin fold [1,2]. Grx1 and Grx3 from Escherichia coli
are the smallest members (9 kDa) in the thioredoxin super-
family including this fold. All thiol-disul¢de oxidoreductases
contain the active site sequence -C-X-X-C-, where the N-ter-
minal active site cysteine thiol has a signi¢cantly lower pKa
value than a free cysteine thiol (pKaV9). The pKa value of
this thiol has been shown to correlate with the redox potential
of the di¡erent enzymes [3,4]. The N-terminal active site thiol
of Trxs is highly nucleophilic with a thiol pKa value of V7
[5]. The corresponding active site thiols of DsbA and PDI
have pKa values of 3.2^3.5 [6] and 4.5 [7] respectively, result-
ing in good leaving group properties for the thiolate anions
[8,9]. Like Trx, Grxs are reducing proteins, with low thiol pKa
values for the N-terminal active site cysteine [10^12]. The
leaving group ability of the thiolate anion is utilized in a
characteristic reaction of Grxs ^ the reduction of glutathione
mixed disul¢des (R-SG). In this reaction Grx reduces peptide-
SG mixed disul¢des with high speci¢city, and the intermediate
Grx-SG mixed disul¢de is subsequently reduced by a second
glutathione molecule [13^15]. The reduction of the Grx-SG
intermediate is facilitated by the favorable leaving group
properties of the Grx active site thiolate [16]. Grxs are also
reductants for the active site disul¢de in ribonucleotide reduc-
tase (RR) [17], in which the intermediate mixed disul¢de be-
tween Grx and RR is released by an intramolecular reaction.
Due to the large impact of the thiol pKa on the redox
potential, considerable e¡ort has been invested to understand
the source of stabilization of the thiolate anion. Studies of Trx
[18^20], PDI [7] and DsbA [4,21], have shown that the resi-
dues between the active site cysteines have a signi¢cant in£u-
ence on the redox potential and thiol pKa, presumably be-
cause of di¡erent electrostatic properties of the mutants.
The problem is, however, more complex, as the redox poten-
tials of E. coli Grx1 and Grx3 di¡er by 35 mV [22] despite
identical active site sequences.
Based on the NMR structure of reduced E. coli Trx, a
hydrogen bond between the N-terminal active site cysteine
thiolate and the C-terminal active site cysteine thiol has
been proposed to stabilize the thiolate anion [23]. The NMR
structure of a quadruple mutant of reduced human Trx
showed no evidence of the corresponding hydrogen bond
[24], but instead the thiolate anion was suggested to be hydro-
gen bonded to the backbone amide of the C-terminal active
site cysteine, as in the structure of the oxidized form [24]. A
later X-ray structure of human Trx did not support this in-
terpretation of the NMR structure of human Trx but instead
demonstrated an active site thiol-thiolate hydrogen bond sim-
ilar to that found in E. coli Trx [25]. Also in a crystal structure
of reduced DsbA, a similar thiol-thiolate hydrogen bond has
been identi¢ed, as well as hydrogen bonds involving the back-
bone amides of His-32 and Cys-33, and the side chain of His-
32 [26].
Here we describe the direct observation of the 1H NMR
resonance of the thiol proton of the C-terminal active site
cysteine, Cys-14, in reduced E. coli Grx3 at 7.6 ppm. The
large down¢eld shift and NOEs observed with this thiol pro-
ton resonance suggest the presence of a hydrogen bond with
the Cys-11 thiolate.
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2. Materials and methods
2.1. Growth and puri¢cation of Grx3
Grx3 enriched in [13CL]-L-cysteine was prepared essentially by the
method described by Jeng et al. [27]. Brie£y, BL-21(DE3) cells con-
taining a pET-Grx3 plasmid were grown at 37‡C in 1 l LB medium.
Approximately 30 min prior to induction, the medium was supple-
mented with 50 mg of [13CL]-L-cysteine and once an OD600 of 0.5 was
reached, expression was induced with 0.5 mM IPTG (¢nal concentra-
tion). The induced cells were harvested after 6 h by centrifugation.
The bacterial pellet was dissolved in 6 volumes of 50 mM Tris-Cl,
1 mM EDTA, pH 7.5 and lysed using a combination of lysozyme (0.2
mg/ml) and sonication. The crude extract obtained after centrifuga-
tion was heated to 75‡C for 5 min, whereafter precipitated protein was
sedimented by centrifugation and discarded. The supernatant was
dialyzed extensively against 20 mM Tris-Cl, 1 mM EDTA, pH 9.5
and applied to a 150 ml column of DEAE-cellulose (DE-52 What-
man) equilibrated with the same bu¡er. The column was washed with
one volume of 10 mM Tris-Cl, 1 mM EDTA, pH 9.5 and subse-
quently eluted with 1 l 50 mM Tris-Cl, 1 mM EDTA, pH 8.0. The
eluted protein was concentrated by ultra¢ltration using a YM-3 mem-
brane (Millipore). The concentrated protein was applied to a column
(100 cmU3 cm2) of Sephadex G-50 (Pharmacia Biotech Inc.), equili-
brated with 100 mM potassium phosphate, 1 mM EDTA, pH 7.0.
Mutants of Grx3 (E9S, C14S, C14A, H15V and C65Y) were con-
structed by PCR using mutagenic primers (Aî slund, F., Spyrou, G.
and Holmgren, A., unpublished results). The Grx3 mutants were ex-
pressed without the supplement of [13CL]-L-cysteine. Otherwise, ex-
pression and puri¢cation followed the protocol described above.
2.2. Enzyme activity assay
The standard coupled assay for glutaredoxin activity, using L-hy-
droxyethyl disul¢de (HED assay) was performed as described by
Holmgren [15]. A standard of puri¢ed E. coli Grx1 was used in
each experiment as a positive control. One unit was de¢ned as the
oxidation of one Wmol of NADPH per min [28]. Speci¢c activity was
de¢ned as units per mg enzyme.
2.3. Isoelectric focusing
Native isoelectric focusing of the reduced and oxidized forms of
Grx3 C65Y was performed on the Pharmacia PhastSystem using a
PhastGel IEF 3-9. The Grx3 C65Y mutant was used in the experiment
to avoid dimerization of the oxidized protein. Reduced Grx3 was
prepared by pre-incubation with 10 mM DTT.
2.4. NMR data collection
All NMR spectra were recorded at 28‡C and a 1H frequency of 600
MHz on a Bruker DMX 600 NMR spectrometer. The COSY and
NOESY spectra of wild-type Grx3 were available from a previous
study [29]. 13C-HSQC spectra [30] were recorded using Grx3 samples
enriched in [13CL]-cysteine. Each spectrum was recorded with
t1max = 100 ms, t2max = 205 ms and a total recording time of 35 min.
2.5. Determination of pKa values from NMR data
A total of 19 13C-HSQC spectra were recorded at di¡erent pH
values between 5.2^11.0. The pH of each sample was measured before
and after recording the NMR spectrum. The pKa of the cysteine thiols
were determined by ¢tting the data to the Henderson^Hasselbalch
equation
N  NHA3 NHA3NA=1 10pKa3pH
n o
1
where N is the measured chemical shift of the L-carbon, and NHA and
NA are the corresponding 13CL chemical shifts of the protonated and
deprotonated side chain respectively. As full transitions were not ob-
served and the number of data points was not su⁄cient to accurately
de¢ne the in£ection point, only upper or lower limits for the pKa
values could be obtained.
3. Results
3.1. The N-terminal active site cysteine has a pKa6 5.5
The isoelectric focusing gel (Fig. 1) shows that Grx3 under-
goes a shift in pI from 6.5 in the oxidized protein to 5.5 in the
reduced form. This shift corresponds to a gain of a net neg-
ative charge upon reduction consistent with a fully ionized
Cys-11 thiolate in reduced Grx3. A similar shift to higher pI
upon oxidation has been noted for rat liver [31] and pig liver
[32] Grx. Furthermore, the pH titration of reduced Grx3
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Fig. 1. Isoelectric focusing gel of Grx3 C65Y. Lane 1, pI standard;
lane 2, reduced Grx3 C65Y; lane 3, oxidized Grx3 C65Y.
Fig. 2. Cysteine 13CL chemical shifts in reduced Grx3 vs. pH.
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(Fig. 2) shows a change in 13C chemical shift for Cys-11 CL
below pH 6.5. Since the protein starts to unfold at pH values
below 5.5, as judged from the disappearance of high and low
¢eld shifted resonances characteristic of the folded protein,
the titration of the native protein could no longer be followed.
It seems clear, however, that the thiol of Cys-11 has a
pKa6 5.5, and is thus largely in the anionic form at physio-
logical pH.
The 13C chemical shift of Cys-14 CL did not change be-
tween pH 5.5 and 10.5 (Fig. 2). As the thiol proton is ob-
served in 1H NMR spectra at pH 6 (see below), the pKa of the
Cys-14 thiol must be s 10.5. The third cysteine present in
native Grx3, Cys-65 [29], has a pKas 10 (Fig. 2). As the
titration experiments were performed in the presence of
DTT to maintain the protein in the reduced form, the thiol
pKa of DTT was measured by the same set of experiments
from its 13C chemical shifts (at natural abundance). The value
determined for the thiol pKa of DTT was 9.2, and in agree-
ment with literature data [8].
3.2. Conserved active site conformation in reduced Grx3
NMR spectra of wild-type Grx (WT-Grx) and the double
mutant Grx3 C14S-C65Y in a mixed disul¢de with gluta-
thione [33] (Grx-SG) show very similar chemical shifts, cou-
pling constants and relative NOE intensities for almost all
protons of the active site residues. Active site residues for
which larger di¡erences were observed between WT-Grx and
Grx3-SG are listed in Table 1. The close similarity of the
NMR parameters indicates that the reduction of Grx3-SG
results in only minor conformational changes. A comparison
of the chemical shift di¡erences between the side chain pro-
tons of residue 14 is not meaningful, as this residue is cysteine
in WT-Grx3 but serine in Grx3-SG, which is needed to trap
the complex. Signi¢cant chemical shift changes include the
amide protons of Tyr-13, Cys-14 and His-15, as well as Tyr-
13 HK. Of all protons in Grx3-SG, these are the ones closest
to the Cys-11 SQ in the NMR structure and they make no van
der Waals contacts with glutathione. The large down¢eld
shifts observed in reduced Grx3 strongly suggest that the
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Fig. 3. Slices from COSY, TOCSY (80 ms mixing time) and NOESY (60 ms mixing time) spectra of reduced Grx3, showing cross peaks be-
tween Cys-11 and Cys-14.
Table 1
Comparison of 1H chemical shifts (ppm) and coupling constants (Hz) for selected residues in the active site of E. coli Grx3 in the reduced
form (Grx3 red.) at pH 6.8 and in the mixed disul¢de complex between Grx3 C14S/C65Y and glutathione (Grx3-SG at pH 6.0); large di¡eren-
ces are highlighted
HN HK HL2 HL3 HQ 3JHNHK 3JHKHL2 3JHKHL3 3JHL2HQ 3JHL3HQ
Residue 13
Grx3 red. 9.43 4.37 3.25 3.02 8.7 largea smalla
Grx3-SG 6.61 3.63 3.17 2.89 4.9 largea smalla
Residue 14
Grx3 red (Cys) 9.79 3.94 2.63 3.60 7.61 6.8 smalla largea largea smalla
Grx3-SG (Ser) 7.40 3.97 3.58 4.32 5.54 7.6 smalla largea largea smalla
Residue 15
Grx3 red. 8.09 4.20 3.23b 3.23b 4.4 ^b ^b
Grx3-SG 7.05 4.17 3.18b 3.18b 4.5 ^b ^b
a‘Large’ and ‘small’ refer to COSY multiplet patterns indicative of trans and gauche conformations of the respective H-N-C-H and H-C-C-H
moieties.
bDegenerate L-proton resonances.
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same protons are also near the charged thiolate anion in re-
duced Grx3. For comparison, the chemical shift change ob-
served for the amide proton of Val-52, which forms a hydro-
gen bond with glutathione [33] was only 0.69 ppm.
A remarkable chemical shift of 7.6 ppm was found for the
Cys-14 thiol proton, HQ (Fig. 3). To date, no thiol protons
have been reported for the thiol-disul¢de oxidoreductases and
they are quite generally rarely observed in NMR studies of
proteins and peptides. Among the 174033 chemical shifts cur-
rently deposited in the BioMagResBank (January 1999), a
total of ¢ve thiol proton chemical shifts are reported, which
are in the range 1.90^5.05 ppm. A random coil chemical shift
of approximately 1.9 ppm at 25‡C has been reported for cys-
teine in aqueous solution [34]. The large down¢eld shift of
Cys-14 HQ is indicative of hydrogen bonding. The thiolate
anion of Cys-11 is the most likely hydrogen bond acceptor,
since Cys-14 HQ makes stronger NOEs with the L-protons of
Cys-11 than those of Cys-14 (Fig. 3).
3.3. C14S, C14A and H15V Grx3 mutants have reduced
activity
To test the putative stabilizing e¡ect of the Cys-14 thiol on
the Cys-11 thiolate, two mutants, Grx3 C14S and Grx3 C14A,
were tested for their activity in the Grx activity assay (HED
assay, Table 2). The conservative mutation to serine resulted
in a 65% reduction of activity [31]. The mutation of Cys-14 to
Ala resulted in a complete loss of activity. To assess the im-
portance of electrostatic interactions with residues in the vi-
cinity of the active site, two additional mutants, Grx3 H15V
and Grx3 E9S were tested by the activity assay. Of the resi-
dues with charged side chains, His-15 is closest to the active
site, whereas the side chain of Glu-9 is rotated away from the
active site in the Grx3-SG structure. Conceivably, a positive
charge on His-15 could stabilize the Cys-11 thiolate. The ac-
tivity of the Grx3 H15V mutant was 19% of that of WT-Grx,
suggesting that the side chain of His-15 indeed contributes to
the stabilization of the Cys-11 thiolate. In contrast, the Grx3
E9S mutant was found to be equally active as the wild-type
protein. This demonstrates that the stabilization of the thio-
late depends more strongly on the charges near the active site
rather than the overall charge of the protein.
4. Discussion
NMR spectra of reduced wild-type Grx3 contain the HQ
proton resonance of Cys-14 even when the water resonance
is suppressed by selective pre-irradiation. This indicates that
the HQ proton is protected from rapid exchange with bulk
water, by hydrogen bonding or because of restricted solvent
accessibility due to burial in the interior of the protein. The
unusually large down¢eld shift of this proton resonance can
be explained by a hydrogen bonding interaction with the neg-
atively charged Cys-11 thiolate anion. Signi¢cant down¢eld
shifts were also observed for the HN resonances of Tyr-13
and Cys-14 in reduced Grx3 compared to their chemical shifts
in Grx3-SG. Both amide groups are potential hydrogen bond
donors for the active site thiolate. Multiple hydrogen bonds
stabilizing the thiolate would be analogous to the situation
found in reduced DsbA [26]. Hydrogen bonding with the thiol
of Cys-14 seems to be an important factor for the low pKa
value of the Cys-11 thiol in Grx3. This conclusion is corrobo-
rated by the fact that Grx3 C14S and Grx3 C14A mutants
displayed little and no activity, respectively, in the HED as-
say. The rate limiting step in this assay is thought to be the
reduction of a Grx-SG intermediate by glutathione [16], i.e.
increased leaving group ability due to stabilization of the thi-
olate anion should be re£ected by enhanced activity in this
assay.
In addition to hydrogen bonding, longer range electrostatic
e¡ects can also contribute to the stabilization of the thiolate
anion in Grx3. Thus, a Grx3 H15V mutant displayed de-
creased reactivity in the activity assay, indicating a stabilizing
interaction with the histidine side chain. In pig liver Grx an
arginine side chain is found at the corresponding position of
His-15 in Grx3, and the corresponding mutation, R26V, was
shown to reduce the activity by 68% [10]. Quite generally, a
positively charged residue following the -C-P-Y-C- sequence
seems to stabilize the active site thiolate, enhancing Grx ac-
tivity [35].
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